×

[Editorial] Postacute stroke care: same standards as acute care?

The Sentinel Stroke National Audit Programme (SSNAP), led by the Royal College of Physicians, has released the first comprehensive audit into 604 of 756 postacute stroke care services throughout the UK. Although vast improvements have been achieved in acute stroke care in recent years, progress in postacute care for long-term rehabilitation has been left behind in comparison.

[Correspondence] Could upright posture be harmful in the early stages of stroke?

Findings from the AVERT trial (July 4, p 46)1 have effectively slain a long cherished theory of stroke unit enthusiasts, that the sooner mobilisation and active rehabilitation begin after stroke, the better. In fact, evidence of a small, but significant, harmful effect of early mobilisation was found. After adjusting for age and stroke severity, and applying the prespecified cutoff for favourable outcome on the modified Rankin scale, we estimate that one in 13 patients (95% CI 8–40) had worse outcome with early mobilisation than with standard treatment.

[Perspectives] Transgression and redemption

In Duncan Macmillan’s new play People, Places and Things, Emma (played by Denise Gough) is a talented actress in trouble. She’s addicted to alcohol and prescription benzodiazepines; we first meet her as she flounders drunkenly onstage during a production of The Seagull. Recognising that her life is unravelling, Emma checks herself into a rehabilitation unit. Her hopes are for a quick fix, followed by a letter of fitness to allow her to return to work.

Effect of older age on treatment decisions and outcomes among patients with traumatic spinal cord injury [Research]

Background:

Older people are at increased risk of traumatic spinal cord injury from falls. We evaluated the impact of older age (≥ 70 yr) on treatment decisions and outcomes.

Methods:

We identified patients with traumatic spinal cord injury for whom consent and detailed data were available from among patients recruited (2004–2013) at any of the 31 acute care and rehabilitation hospitals participating in the Rick Hansen Spinal Cord Injury Registry. Patients were assessed by age group (< 70 v. ≥ 70 yr). The primary outcome was the rate of acute surgical treatment. We used bivariate and multivariate regression models to assess patient and injury-related factors associated with receiving surgical treatment and with the timing of surgery after arrival to a participating centre.

Results:

Of the 1440 patients included in our study cohort, 167 (11.6%) were 70 years or older at the time of injury. Older patients were more likely than younger patients to be injured by falling (83.1% v. 37.4%; p < 0.001), to have a cervical injury (78.0% v. 61.6%; p = 0.001), to have less severe injuries on admission (American Spinal Injury Association Impairment Scale grade C or D: 70.5% v. 46.9%; p < 0.001), to have a longer stay in an acute care hospital (median 35 v. 28 d; p < 0.005) and to have a higher in-hospital mortality (4.2% v. 0.6%; p < 0.001). Multivariate analysis did not show that age of 70 years or more at injury was associated with a decreased likelihood of surgical treatment (adjusted odds ratio [OR] 0.48, 95% confidence interval [CI] 0.22–1.07). An unplanned sensitivity analysis with different age thresholds showed that a threshold of 65 years was associated with a decreased chance of surgical treatment (OR 0.39, 95% CI 0.19–0.80). Older patients who underwent surgical treatment had a significantly longer wait time from admission to surgery than younger patients (37 v. 19 h; p < 0.001).

Interpretation:

We found chronological age to be a factor influencing treatment decisions but not at the 70-year age threshold that we had hypothesized. Older patients waited longer for surgery and had a substantially higher in-hospital mortality despite having less severe injuries than younger patients. Further research into the link between treatment delays and outcomes among older patients could inform surgical guideline development.

[Editorial] New guidelines for idiopathic pulmonary fibrosis

International experts in idiopathic pulmonary fibrosis (IPF) have issued new treatment guidelines to reflect the advances made recently in this terminal disease. Survival for people with IPF—a chronic, progressive, fibrosing form of interstitial pneumonia—was historically around 50% at 3 years. Treatment options have centred on best supportive care including oxygen and pulmonary rehabilitation. Pharmacological disease-modifying interventions have been disappointing. Combination therapy with prednisone, azathioprine, and N-acetylcysteine showed promise, but the results of the PANTHER-IPF study showed an excess of deaths and serious adverse events without evidence of benefit.

[Comment] AVERT: a major milestone in stroke research

Prevention of stroke is, of course, the ideal scenario, but with more than 10 million major strokes every year worldwide, acute treatment and rehabilitation should also be optimised. Organised acute stroke care within dedicated stroke units reduces death and dependency after stroke,1 but which elements of such care confer this benefit is uncertain. Systematic prevention of common complications and more expert nursing care undoubtedly contribute, but in the physiologically unstable setting of acute stroke, the benefits and harms of each specific element of care need to be reliably assessed.

Smartphone app a lifesaver for patients after myocardial infarction

Clinical guidelines recommend that patients complete a cardiac rehabilitation program after experiencing a myocardial infarction, with studies showing that those who do have much better long-term health outcomes.

Despite the benefits, uptake of traditional cardiac rehabilitation programs is poor. Many patients find weekly travel to a health facility to be difficult. This is particularly so for those who work, care for others or live in regional Australia where these services are not available.

To overcome this problem, the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and Queensland Health have developed a home-based cardiac rehabilitation program delivered via a smartphone app, called the Care Assessment Platform. This home-based program features health and exercise tools, motivational materials and multimedia delivered through the app to educate patients about disease management, and remote mentoring consultations.

A clinical trial conducted through the Australian e-Health Research Centre showed that this delivery model achieved equal or better clinical outcomes compared with a traditional rehabilitation program (Heart 2014; 100: 1770-1779). Patients recovering from myocardial infarctions were almost 30% more likely to take part in rehabilitation at home using the smartphone app, compared with those who had to travel to an outpatient clinic. Patients were also 40% more likely to adhere to the rules of the program and almost 70% more likely to complete it than those in traditional rehabilitation programs.

Most importantly, this delivery model offers a more flexible option. By integrating rehabilitation into patients’ daily lives, they are more likely to complete the program and make the healthy changes to their lifestyle permanent. This overcomes one of the key barriers to patient participation and recovery.

The Care Assessment Platform will soon be offered in several Queensland hospitals. The research team is also looking to adapt the technology for use with other chronic conditions, such as pulmonary disease and diabetes.

Partial foot amputations may not always be worth the risk of complications

In reply: We appreciate the opportunity to reply to two letters submitted in response to our article.1

Both letters agree that our perspective piece was mainly based on evidence about the outcomes for people with transmetatarsal amputation, noting that most people undergo amputation of the toe(s) or toes and metatarsals. As highlighted in our supporting work,2 there are comparatively few investigations focusing on outcomes for people with digital, ray, tarsometatarsal and transtarsal amputation. Despite this, we stand by our interpretation that the rates of complications and reamputation seem very similar across levels of partial foot amputation.1,2 To illustrate, a study that stratified large numbers of people by level of partial foot amputation found that the rates of ipsilateral reamputation were not statistically different in groups with either toe, ray or mid-foot (ie, transmetatarsal, Lisfranc and Chopart) amputation.3 Given these data, we argue that our synthesis of published outcomes on the rates of reamputation and other complications for people with different levels of partial foot amputation was reasonable. Our article should not be considered a comparison between the outcomes of transmetatarsal and transtibial amputation.

We do not believe that current data show that toe amputations are becoming more common in Australia. The age-standardised incidence of toe amputation remained stable between 2000 and 2010, while the incidence of partial foot amputation at the toe and metatarsal level and transmetatarsal level increased.4

We are not advocating that more transtibial amputations should be considered to minimise the risk of complications and further amputations. Rather, clinicians should consider the emerging evidence when communicating the perceived benefits to patients; particularly given that this evidence challenges long-held beliefs.2

We are grateful for the opportunity to promote discussion and highlight awareness of the need for further research into outcomes for people facing difficult decisions about limb loss.

Partial foot amputation may not always be worth the risk of complications

Similarity in functional outcomes with partial foot and transtibial amputation focuses attention on complication rates

Partial foot amputation is increasingly common in Australia,1 and the rates of complications are disproportionately high compared with people who have transtibial (below-knee) amputation.2We draw attention to these recent observations in our publications, highlighting that contemporary beliefs about partial foot amputations do not always result in optimal outcomes, especially for older people.1,3

A lower limb amputation is performed in Australia nearly every hour. Of the 8000 lower limb amputations in Australia each year,1 many are the end result of the long-term complications of diabetes such as peripheral vascular disease, neuropathy and chronic non-healing ulceration of the foot.

There has been a considerable shift in the types of lower limb amputations performed in Australia over the past decade.1 The incidence of transfemoral and transtibial amputation has declined and the incidence of partial foot amputation has increased.1 In Australia three-quarters of all lower limb amputations are now at the partial foot level.1

The shift to more distal amputation could be seen by some as a positive outcome. However, partial foot amputation can be associated with disproportionately high rates of complications and revision surgery. Between 30% and 50% of people with partial foot amputation experience complications such as dehiscence, ulceration or wound failure.4,5 However, these sorts of wound complications seem to affect just 10%–20% of people with transtibial amputation.68 Only around half of all partial foot amputations heal adequately.4,7 Efforts to achieve wound healing after partial foot amputation often occur over many months and cost between $27 000 and $36 000 depending on the treatment approach used.9 In comparison with the low rates of healing in partial foot amputation, around 80% of transtibial amputations heal.10,11 Subsequent amputation on the same limb is necessary in about one-third of people with an initial partial foot amputation; more than double that observed in people with an initial transtibial amputation.2,4

The high risk of complications and secondary amputation are sometimes considered reasonable when weighed against the functional benefits of partial foot amputation.12,13 Implicit in this reasoning is the belief that, if successful, partial foot amputation will lead to improved outcomes compared with transtibial amputation.

Emerging research suggests that many functional outcomes are similar in people with partial foot and transtibial amputation. For example, once the metatarsal heads are removed, people with partial foot and transtibial amputations have a strikingly similar gait pattern: power generation at the ankle is negligible and the hip joints provide the compensatory work required to walk.3 Similarly, walking speed and energy expenditure are also much the same.3 In terms of quality of life, only descriptive data are available. While these data suggest that quality of life is similar in both groups,3 we do not know whether the purported benefits of partial foot amputation, like walking short distances without a prosthesis,5 are important from the patient’s perspective. The lower mortality associated with partial foot amputation may have nothing to do with the amputation procedure per se.14 It is likely that people considered suitable candidates for partial foot amputation live longer because they have less advanced vascular disease than those requiring a transtibial amputation.

Considering that the functional outcomes for people with partial foot and transtibial amputation are similar, it is difficult to understand why the high risk of complications and secondary amputation associated with partial foot amputation do not weigh more heavily in decisions about amputation surgery. Arguably, minimising complications and repeat surgeries should be the primary goal given that most people are in the last years of their life, are often chronically unwell and have limited mobility.

When viewed from the patient’s perspective, it is perhaps easier to understand: individuals faced with the difficult reality of lower limb amputation often choose the procedure that preserves as much of their foot as possible. Yet when informing these decisions, clinicians have an obligation to provide information consistent with the emerging evidence, which suggests that people with partial foot amputation have very similar functional outcomes compared with those with transtibial amputation, yet markedly greater risks of complications and secondary amputation on the same limb.3

With a better understanding of the research data, we contend that more people might initially choose a more invasive procedure to minimise the risk of complications and further amputation surgery in the future.

If further research supports our interpretation of the emerging evidence,1,3 there will be a strong case for choosing between partial foot and transtibial amputation based on the likelihood of healing rather than perceived functional benefits. With this approach, more first amputations are more likely to be final ones.